Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2023 | What does the future hold for multi-cancer early detection blood tests?

Tom Beer • 22 Oct 2023
ESMO 2023
General

Tom Beer, MD, Exact Sciences, Madison, WI, comments on the future of multi-cancer early detection (MCED) blood tests in detecting cancer. Following on from the success of the test in the DETECT-A study, further prospective studies are underway to further evaluate efficacy and safety in patients. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Tom Beer

1:32
The effect of MCED blood tests on patient screening and mental wellbeing
Tom Beer • 22 Oct 2023
0:43
Multi-cancer early detection tests in cancer
Tom Beer • 22 Oct 2023

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals